• 病理学p53肿瘤抑制基因突变第11p15基因座杂和丢失

    Pathology: p53 tumor suppressor gene mutation, loss of heterozygosity (LOH) at 11p15 locus. PAX-FKHR gene fusion.

    youdao

  • 氧化应激可以导致DNA断裂、DNA位点突变、DNA双链畸变基因肿瘤抑制基因突变形式的DNA损伤

    Oxidative stress can cause DNA damage, such as DNA strand breaks, point mutations, aberrant DNA cross-linking, and mutations in proto-oncogenes and tumor suppressor genes;

    youdao

  • 该药物能够准确正确染色体数目导入一新细胞产生整倍体细胞,能够用于治疗由于肿瘤抑制基因突变导致肿瘤

    Drugs that inhibit accurate delivery of the right number of chromosomes to each new cell, resulting in aneuploidy, would be used to destroy tumors caused by mutations in the tumor suppressors.

    youdao

  • 从不吸烟患者一类表皮生长因子受体抑制药物反应更好因为类患者有表皮生长因子受体基因突变可能性大一些。”鲁丁

    "Patients who never smoked respond better to a certain class of drugs called EGFR inhibitors, because lung cancer in these patients more often contain mutations in the EGFR gene," Rudin says.

    youdao

  • 其他基因突变可以抑制肿瘤,是人体对抗基因突变而产生危险天然防御机制。

    The other mutated genes seemed to be tumor suppressors, the body's natural defense against dangerous genetic mistakes.

    youdao

  • NF 1基因突变导致肿瘤抑制异常,可发生各种各样良性恶性肿瘤

    The genetic mutation of the NF1 leads to abnormal tumor suppression, leading to a variety of benign and malignant tumors.

    youdao

  • 目的探讨蜂胶环磷酰胺等诱变剂诱发基因突变抑制作用

    Objective: To study the effects of propolis against gene mutation induced by powerful mutagens in mice.

    youdao

  • KRAS基因突变恶性肿瘤组织中频发,预测细胞肺癌分子靶向治疗疗效预后针对RAS基因的分子抑制剂研究处于初级阶段。

    KRAS mutation frequency in tumor tissue, can be predicted non-small cell lung cancer molecular targeted therapy efficacy and prognosis, and molecular inhibitors of RAS genes is still in its infancy.

    youdao

  • 这种互相作用环境(细胞质)某些因素引起基因突变基因活化抑制

    It does not seem that in this interaction some factors of environment (cytoplasm) lead to the gene mutation or the activation and check of the gene.

    youdao

  • PTEN肿瘤抑制因子乳腺癌中虽表达并不是通过基因突变促进子甲基化而实现的,因此其失表达机制还不清楚。

    Expression of the PTEN tumor suppressor is frequently lost in breast cancer in the absence of mutation or promoter methylation through as yet undetermined mechanisms.

    youdao

  • 研究者希望,通过基因突变相关蛋白结构深入了解可以开发出有效的药物治疗抑制突变基因的激活。

    The researchers hope that understanding more about the gene's mutations and the structure of the protein may lead to drug treatments to help ensure that mutant copies of the gene are inactive.

    youdao

  • 不同基因突变改变功能活动基因可以抑制一种非常合适药物失去基因树叶什么药物目标

    Unlike a genetic mutation that changes the function or activity of a gene, which can be inhibited by a well-tailored drug, loss of a gene leaves nothing for the drug to target.

    youdao

  • FBW7一种肿瘤抑制蛋白基因多种肿瘤包括直肠癌胃癌卵巢癌白血病中存在着基因突变缺失

    FBW7 is a tumor suppressor, and its gene is frequently mutated or deleted in various human cancers including colorectal, gastric, ovarian and leukemias.

    youdao

  • FBW7一种肿瘤抑制蛋白基因多种肿瘤包括直肠癌胃癌卵巢癌白血病中存在着基因突变缺失

    FBW7 is a tumor suppressor, and its gene is frequently mutated or deleted in various human cancers including colorectal, gastric, ovarian and leukemias.

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定